Elpis Chochliourou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Elpis Chochliourou has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Despoina Ioannou
Research Team “Histologistas”, Interinstitutional Postgraduate Program “Health and Environmental Factors”, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece
4 shared publications - Dimosthenis Sarigiannis
Environmental Engineering Laboratory, Department of Chemical Engineering, Aristotle University of Thessaloniki, Thessaloniki, Greece
4 shared publications - Maria-Nefeli Georgaki
“Histologistas” Research Group, Interinstitutional Postgraduate Program “Health and Environmental Factors”, Medical School, Faculty of Health Sciences, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece
4 shared publications - Kanellos Skourtsidis
Research Team “Histologistas”, Interinstitutional Postgraduate Program “Health and Environmental Factors”, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece
3 shared publications - Theodora Papamitsou
Research Team “Histologistas”, Interinstitutional Postgraduate Program “Health and Environmental Factors”, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece
3 shared publications - Alexandra Skarlatou
Neonatal Intensive Care Unit, Pediatric Department, Democritus University of Thrace, University General Hospital of Alexandroupolis, 68100 Alexandroupolis, Greece
2 shared publications
Latest Publications
- Open Access
- 10 November 2026
- Published by MDPI AG in Advances in Respiratory Medicine
- Vol. 94 (6) , 78
Ventilating Pediatric Critical Asthma: Why Validated, Disease-Specific Targets Are Still Missing—A Narrative Review and Proposed Research Framework
Pediatric acute respiratory distress syndrome (PARDS) has an international, evidence-graded consensus guideline (PALICC-2). PALICC-2 excludes respiratory failure caused solely by airway obstruction. The Paediatric Mechanical Ventilation Consensus Conference (PEMVECC) provides general recommendations for obstructive airway disease, and the 2025 AARC/PALISI guideline on paediatric critical asthma does not address invasive ventilation. Validated, outcome-linked ventilator targets for critical asthma and a severity metric for the intubated child are still missing. This narrative review examines five possible explanations: heterogeneity of obstruction and overlap with parenchymal disease; loss of severity assessment after intubation; the small number of ventilated children; a haemodynamic hazard that develops over minutes to hours; and the brevity and instability of the illness. Adult critical care has the same gap. We pay most attention to the missing severity metric, a daily obstacle for clinicians, although solving it would not alone produce a guideline. We propose a research framework in which physiological validation and consensus development proceed in parallel. PARDS is used only as a comparator; the two conditions are distinct diseases.
- 10 November 2026
- Published by MDPI AG in Advances in Respiratory Medicine
- Vol. 94 (6) , 78
Open AccessVentilating Pediatric Critical Asthma: Why Validated, Disease-Specific Targets Are Still Missing—A Narrative Review and Proposed Research Framework
Pediatric acute respiratory distress syndrome (PARDS) has an international, evidence-graded consensus guideline (PALICC-2). PALICC-2 excludes respiratory failure caused solely by airway obstruction. The Paediatric Mechanical Ventilation Consensus Conference (PEMVECC) provides general recommendations for obstructive airway disease, and the 2025 AARC/PALISI guideline on paediatric critical asthma does not address invasive ventilation. Validated, outcome-linked ventilator targets for critical asthma and a severity metric for the intubated child are still missing. This narrative review examines five possible explanations: heterogeneity of obstruction and overlap with parenchymal disease; loss of severity assessment after intubation; the small number of ventilated children; a haemodynamic hazard that develops over minutes to hours; and the brevity and instability of the illness. Adult critical care has the same gap. We pay most attention to the missing severity metric, a daily obstacle for clinicians, although solving it would not alone produce a guideline. We propose a research framework in which physiological validation and consensus development proceed in parallel. PARDS is used only as a comparator; the two conditions are distinct diseases.
- 31 July 2026
- Published by Springer Nature in Journal of Cluster Science
- Vol. 37 (5) , 131
Copper in the Nanotechnology Era: A Systematic Review of Antimicrobial Implications
- 31 July 2026
- Published by Springer Nature in Journal of Cluster Science
- Vol. 37 (5) , 131
Copper in the Nanotechnology Era: A Systematic Review of Antimicrobial Implications
- 20 July 2026
- Published by Wolters Kluwer Health in Journal of Craniofacial Surgery
Giant Lipoma of the Temporal Region Extending Into the Buccal Space: Radiologic, Surgical, and Molecular Correlation
Lipomas are common benign tumors of adipose tissue; however, their occurrence in the head and neck region, particularly within deep facial compartments, is relatively uncommon. Lesions arising in the buccal space may pose diagnostic and surgical challenges due to their proximity to critical anatomic structures. A 69-year-old female presented with a gradually enlarging, painless swelling of the right midface, resulting in facial asymmetry. Clinical examination identified a soft, mobile mass without neurological deficit. Magnetic resonance imaging revealed a well-circumscribed lesion within the right buccal space, with signal characteristics consistent with adipose tissue. Surgical excision was performed, and the specimen measured 8.5 × 5.5 × 2 cm. Histopathologic analysis confirmed a benign lipoma composed of mature adipocytes without atypia. Molecular assessment using fluorescence in situ hybridization showed no MDM2 gene amplification, ruling out an atypical lipomatous tumor. The postoperative course was uneventful, with preservation of facial nerve function and a satisfactory aesthetic result. Lipomas of deep facial compartments are uncommon and may mimic other pathologies. Accurate diagnosis relies on correlation of clinical findings with imaging, histopathology, and, when necessary, molecular analysis. Surgical excision remains the treatment of choice and is associated with favorable outcomes.
- 20 July 2026
- Published by Wolters Kluwer Health in Journal of Craniofacial Surgery
Giant Lipoma of the Temporal Region Extending Into the Buccal Space: Radiologic, Surgical, and Molecular Correlation
Lipomas are common benign tumors of adipose tissue; however, their occurrence in the head and neck region, particularly within deep facial compartments, is relatively uncommon. Lesions arising in the buccal space may pose diagnostic and surgical challenges due to their proximity to critical anatomic structures. A 69-year-old female presented with a gradually enlarging, painless swelling of the right midface, resulting in facial asymmetry. Clinical examination identified a soft, mobile mass without neurological deficit. Magnetic resonance imaging revealed a well-circumscribed lesion within the right buccal space, with signal characteristics consistent with adipose tissue. Surgical excision was performed, and the specimen measured 8.5 × 5.5 × 2 cm. Histopathologic analysis confirmed a benign lipoma composed of mature adipocytes without atypia. Molecular assessment using fluorescence in situ hybridization showed no MDM2 gene amplification, ruling out an atypical lipomatous tumor. The postoperative course was uneventful, with preservation of facial nerve function and a satisfactory aesthetic result. Lipomas of deep facial compartments are uncommon and may mimic other pathologies. Accurate diagnosis relies on correlation of clinical findings with imaging, histopathology, and, when necessary, molecular analysis. Surgical excision remains the treatment of choice and is associated with favorable outcomes.
- Open Access
- 24 June 2026
- Published by MDPI AG in Environmental and Earth Sciences Proceedings
- Vol. 44 (1) , 25
SEM Analysis of Red Blood Cell Morphology as a Biomarker in Agricultural and Industrial Environments: Initial Findings in Exposome Research
Red blood cells (RBCs) are sensitive biomarkers of human health, influenced by urbanization and agricultural exposures. Using scanning electron microscopy (SEM) within an exposome framework, we examined RBC morphology in residents of an industrialized area of Thessaloniki, Greece, and in a rural population primarily exposed to agricultural stressors. Blood samples and questionnaires covering demographics, lifestyle, and environmental factors were statistically analyzed. SEM revealed moderate morphological alterations without significant differences between groups. Observed features were associated with longer residence duration and suboptimal nutrition, suggesting subclinical cellular stress. Integrating these findings into exposome research may clarify cumulative industrial and agricultural impacts on RBC morphology.
- 24 June 2026
- Published by MDPI AG in Environmental and Earth Sciences Proceedings
- Vol. 44 (1) , 25
Open AccessSEM Analysis of Red Blood Cell Morphology as a Biomarker in Agricultural and Industrial Environments: Initial Findings in Exposome Research
Red blood cells (RBCs) are sensitive biomarkers of human health, influenced by urbanization and agricultural exposures. Using scanning electron microscopy (SEM) within an exposome framework, we examined RBC morphology in residents of an industrialized area of Thessaloniki, Greece, and in a rural population primarily exposed to agricultural stressors. Blood samples and questionnaires covering demographics, lifestyle, and environmental factors were statistically analyzed. SEM revealed moderate morphological alterations without significant differences between groups. Observed features were associated with longer residence duration and suboptimal nutrition, suggesting subclinical cellular stress. Integrating these findings into exposome research may clarify cumulative industrial and agricultural impacts on RBC morphology.
- Open Access
- 2 April 2026
- Published by MDPI AG in Journal of Xenobiotics
- Vol. 16 (2) , 59
Environmental Metal Exposure and Brain-Derived Neurotrophic Factor (BDNF): A Systematic Review of Human and Experimental Evidence
Background: Brain-derived neurotrophic factor (BDNF) is central to synaptic plasticity and neurodevelopment. Toxic metal exposure is linked to oxidative stress and neuroinflammation, yet its effects on BDNF signaling remain unclear. Objectives: To systematically synthesize evidence from human and experimental studies on the association between environmental or occupational metal exposure and BDNF alterations, and to highlight research gaps with an emphasis on hexavalent chromium (Cr(VI)). Methods: PubMed, Scopus, and ScienceDirect were searched following PRISMA guidelines. Eligible studies included human observational research and animal models reporting quantitative associations between metal exposure (biomarkers/environmental measures) and BDNF outcomes (protein or gene expression). Data were extracted on exposure assessment, BDNF measurement, and neurobehavioral outcomes. Study quality was assessed using NOS (human studies) and SciRAP (experimental studies). Results: Nineteen studies were included. Across metals such as Pb, Hg, Cd, As, Mn, and mixtures, exposure was associated with altered BDNF levels in blood or brain tissue, often alongside oxidative stress markers, inflammatory changes, and cognitive or behavioral impairment in animal models. Most human studies reported decreased circulating BDNF with higher exposure, while experimental evidence suggested context-dependent regulation across exposure windows and brain regions. Conclusions: The available evidence supports a biologically plausible link between metal exposure and BDNF dysregulation. No eligible studies evaluated BDNF in relation to Cr(VI), indicating a major research gap. Future studies should integrate neurotrophic biomarkers with exposome-oriented designs to clarify chromium-related neurotoxicity and support Adverse Outcome Pathway (AOP)-informed frameworks.
- 2 April 2026
- Published by MDPI AG in Journal of Xenobiotics
- Vol. 16 (2) , 59
Open AccessEnvironmental Metal Exposure and Brain-Derived Neurotrophic Factor (BDNF): A Systematic Review of Human and Experimental Evidence
Background: Brain-derived neurotrophic factor (BDNF) is central to synaptic plasticity and neurodevelopment. Toxic metal exposure is linked to oxidative stress and neuroinflammation, yet its effects on BDNF signaling remain unclear. Objectives: To systematically synthesize evidence from human and experimental studies on the association between environmental or occupational metal exposure and BDNF alterations, and to highlight research gaps with an emphasis on hexavalent chromium (Cr(VI)). Methods: PubMed, Scopus, and ScienceDirect were searched following PRISMA guidelines. Eligible studies included human observational research and animal models reporting quantitative associations between metal exposure (biomarkers/environmental measures) and BDNF outcomes (protein or gene expression). Data were extracted on exposure assessment, BDNF measurement, and neurobehavioral outcomes. Study quality was assessed using NOS (human studies) and SciRAP (experimental studies). Results: Nineteen studies were included. Across metals such as Pb, Hg, Cd, As, Mn, and mixtures, exposure was associated with altered BDNF levels in blood or brain tissue, often alongside oxidative stress markers, inflammatory changes, and cognitive or behavioral impairment in animal models. Most human studies reported decreased circulating BDNF with higher exposure, while experimental evidence suggested context-dependent regulation across exposure windows and brain regions. Conclusions: The available evidence supports a biologically plausible link between metal exposure and BDNF dysregulation. No eligible studies evaluated BDNF in relation to Cr(VI), indicating a major research gap. Future studies should integrate neurotrophic biomarkers with exposome-oriented designs to clarify chromium-related neurotoxicity and support Adverse Outcome Pathway (AOP)-informed frameworks.
- Open Access
Urinary Chromium as a Biomarker of Environmental Exposure: A Review—Current Understanding and Limitations
Chromium (Cr) remains a significant environmental health concern, with exposure mainly through ingestion and inhalation. Its toxicological profile is driven by oxidation state: trivalent chromium [Cr(III)] shows low bioavailability, whereas hexavalent chromium [Cr(VI)] is highly bioavailable, crosses cell membranes, and generates reactive intermediates associated with oxidative and genotoxic effects. Several studies have highlighted the assessment of chromium exposure, particularly Cr(III) and Cr(VI), across different biological matrices as a key approach for accurate exposure characterization. This review synthesizes experimental and epidemiological evidence regarding urinary chromium (uCr) as a biomarker of exposure, alongside advances in analytical techniques and the emerging exposome framework. Although widely used due to non-invasive sampling and suitability for large studies, uCr primarily reflects recent exposure (<48 h), exhibits high intra- and inter-individual variability, and lacks routine Cr(VI)/Cr(III) speciation, limiting its value for low-level environmental exposure. Unlike urinary or whole blood chromium, chromium in red blood cells (RBCs) is specific to Cr(VI) exposure, since in vitro studies reveal selective, donor-independent accumulation of hexavalent chromium in RBCs. However, the current literature is primarily concerned with sampling strategies, pre-treatment procedures, and analytical validation, with comparatively little consideration given to chromium speciation and species interconversion in biological matrices, despite their essential significance for exposure assessment and toxicological interpretation.
Open AccessUrinary Chromium as a Biomarker of Environmental Exposure: A Review—Current Understanding and Limitations
Chromium (Cr) remains a significant environmental health concern, with exposure mainly through ingestion and inhalation. Its toxicological profile is driven by oxidation state: trivalent chromium [Cr(III)] shows low bioavailability, whereas hexavalent chromium [Cr(VI)] is highly bioavailable, crosses cell membranes, and generates reactive intermediates associated with oxidative and genotoxic effects. Several studies have highlighted the assessment of chromium exposure, particularly Cr(III) and Cr(VI), across different biological matrices as a key approach for accurate exposure characterization. This review synthesizes experimental and epidemiological evidence regarding urinary chromium (uCr) as a biomarker of exposure, alongside advances in analytical techniques and the emerging exposome framework. Although widely used due to non-invasive sampling and suitability for large studies, uCr primarily reflects recent exposure (<48 h), exhibits high intra- and inter-individual variability, and lacks routine Cr(VI)/Cr(III) speciation, limiting its value for low-level environmental exposure. Unlike urinary or whole blood chromium, chromium in red blood cells (RBCs) is specific to Cr(VI) exposure, since in vitro studies reveal selective, donor-independent accumulation of hexavalent chromium in RBCs. However, the current literature is primarily concerned with sampling strategies, pre-treatment procedures, and analytical validation, with comparatively little consideration given to chromium speciation and species interconversion in biological matrices, despite their essential significance for exposure assessment and toxicological interpretation.
- Open Access
- 26 February 2026
- Published by MDPI AG in Biomedicines
- Vol. 14 (3) , 517
The Link Between Preterm Birth and Long-Term Renal Consequences: Current Knowledge and Emerging Therapeutic Targets
Background/Objectives: Preterm birth interrupts nephrogenesis during a critical developmental window, resulting in reduced nephron endowment and lifelong renal vulnerability. Evidence indicates that individuals born preterm are at increased risk for hypertension, albuminuria, and chronic kidney disease (CKD) across the life course. This review synthesizes current evidence linking prematurity with adverse renal outcomes, explores key pathophysiological mechanisms, and discusses emerging biomarkers together with therapeutic strategies. Methods: This comprehensive review integrates evidence from clinical cohort studies, population-based registries, meta-analyses and experimental models. Factors such as neonatal acute kidney injury (AKI), nephrotoxic exposures and cardiometabolic interactions were integrated to provide a life-course perspective. Results: Preterm birth leads to reduced nephron endowment, compensatory glomerular hypertrophy, and hyperfiltration, which predispose to progressive nephron loss. Postnatal factors, including neonatal AKI, inflammation, nephrotoxic medications, and later cardiometabolic stress, act as cumulative “hits”, accelerating renal injury trajectories. Clinical studies demonstrate a higher prevalence of reduced estimated glomerular filtration rate, albuminuria, elevated blood pressure, and smaller kidney volumes from childhood into adulthood. Emerging biomarkers such as cystatin C, alongside imaging-based estimates of nephron endowment, may enhance early risk stratification. Conclusions: Preterm birth represents an independent, lifelong risk factor for CKD through combined developmental and postnatal mechanisms. Structured long-term surveillance and early preventive strategies are essential to preserve renal reserve in this population. Advances in biomarker-guided monitoring and targeted interventions may enable earlier identification of high-risk individuals and support precision approaches to nephroprotection after prematurity.
- 26 February 2026
- Published by MDPI AG in Biomedicines
- Vol. 14 (3) , 517
Open AccessThe Link Between Preterm Birth and Long-Term Renal Consequences: Current Knowledge and Emerging Therapeutic Targets
Background/Objectives: Preterm birth interrupts nephrogenesis during a critical developmental window, resulting in reduced nephron endowment and lifelong renal vulnerability. Evidence indicates that individuals born preterm are at increased risk for hypertension, albuminuria, and chronic kidney disease (CKD) across the life course. This review synthesizes current evidence linking prematurity with adverse renal outcomes, explores key pathophysiological mechanisms, and discusses emerging biomarkers together with therapeutic strategies. Methods: This comprehensive review integrates evidence from clinical cohort studies, population-based registries, meta-analyses and experimental models. Factors such as neonatal acute kidney injury (AKI), nephrotoxic exposures and cardiometabolic interactions were integrated to provide a life-course perspective. Results: Preterm birth leads to reduced nephron endowment, compensatory glomerular hypertrophy, and hyperfiltration, which predispose to progressive nephron loss. Postnatal factors, including neonatal AKI, inflammation, nephrotoxic medications, and later cardiometabolic stress, act as cumulative “hits”, accelerating renal injury trajectories. Clinical studies demonstrate a higher prevalence of reduced estimated glomerular filtration rate, albuminuria, elevated blood pressure, and smaller kidney volumes from childhood into adulthood. Emerging biomarkers such as cystatin C, alongside imaging-based estimates of nephron endowment, may enhance early risk stratification. Conclusions: Preterm birth represents an independent, lifelong risk factor for CKD through combined developmental and postnatal mechanisms. Structured long-term surveillance and early preventive strategies are essential to preserve renal reserve in this population. Advances in biomarker-guided monitoring and targeted interventions may enable earlier identification of high-risk individuals and support precision approaches to nephroprotection after prematurity.
- Open Access
Furosemide-Induced Nephrocalcinosis in Premature Neonates: A Critical Review of Observational Data
Background/Objectives: Furosemide is frequently used in preterm neonates for respiratory and fluid management but has been linked to nephrocalcinosis (NC), a renal complication with unclear long-term impact. Clarifying this association is crucial for safe diuretic use. Methods: A focused literature review included observational studies published between 1982 and 2025 reporting NC incidence by renal ultrasound in preterm infants receiving furosemide. Data on sample size, gestational age, birth weight, NC prevalence, and furosemide dosing/duration were extracted. Results were synthesized descriptively. Results: Twenty-two studies with 1489 infants were included. NC prevalence ranged 6–83%, higher in infants p < 0.001). A dose-dependent risk was noted, with odds ratios increasing above a cumulative dose of 10 mg/kg. Some studies found no significant dose–response, indicating variability and confounding factors. NC was detected during NICU stay or around term-equivalent age; ~60% resolved after discontinuation, while persistent cases were associated with prolonged exposure and renal dysfunction. A recent multicenter, dose-escalation randomized trial showed that carefully dosed furosemide (≤2 mg/kg/day for 28 days) did not increase NC risk, though electrolyte disturbances were more frequent. Conclusions: Evidence supports a dose-related association between furosemide and NC in preterm infants. When administered cautiously within defined limits, risk may be mitigated. Careful dosing, monitoring, and further studies are essential for safe use.
Open AccessFurosemide-Induced Nephrocalcinosis in Premature Neonates: A Critical Review of Observational Data
Background/Objectives: Furosemide is frequently used in preterm neonates for respiratory and fluid management but has been linked to nephrocalcinosis (NC), a renal complication with unclear long-term impact. Clarifying this association is crucial for safe diuretic use. Methods: A focused literature review included observational studies published between 1982 and 2025 reporting NC incidence by renal ultrasound in preterm infants receiving furosemide. Data on sample size, gestational age, birth weight, NC prevalence, and furosemide dosing/duration were extracted. Results were synthesized descriptively. Results: Twenty-two studies with 1489 infants were included. NC prevalence ranged 6–83%, higher in infants p < 0.001). A dose-dependent risk was noted, with odds ratios increasing above a cumulative dose of 10 mg/kg. Some studies found no significant dose–response, indicating variability and confounding factors. NC was detected during NICU stay or around term-equivalent age; ~60% resolved after discontinuation, while persistent cases were associated with prolonged exposure and renal dysfunction. A recent multicenter, dose-escalation randomized trial showed that carefully dosed furosemide (≤2 mg/kg/day for 28 days) did not increase NC risk, though electrolyte disturbances were more frequent. Conclusions: Evidence supports a dose-related association between furosemide and NC in preterm infants. When administered cautiously within defined limits, risk may be mitigated. Careful dosing, monitoring, and further studies are essential for safe use.